Back

Epicardial/hybrid atrial fibrillation ablation registry (EHAFAR): how does a hybrid approach compare to a transcatheter approach ?

18 June 2017 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: Atrial fibrillation and ablation or devices: what do registries tell us? Atrial fibrillation ablation EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Madelene Carina Blomstrom-Lundqvist

Orebro University Hospital, Orebro (Sweden)

4 More presentations in this session

Presentation thumbnail
EORP registry: what determines a good outcome from atrial fibrillation ablation in the 'real world'.
Doctor N. Dagres (Berlin, DE)
Presentation thumbnail
European Atrial Fibrillation Ablation Registry: do outcomes in the real-world compare with trials ?
Professor J. Kautzner (Prague, CZ)
Slides Video
Presentation thumbnail
Practice in perspective: can registry data guide future developments in atrial fibrillation ablation?
Doctor J. de Bono (Birmingham, GB)
Slides Video
Presentation thumbnail
Preventing progression of atrial fibrillation: a real-world analysis of a reactive atrial-antitachycardia pacing feature in CIEDs
Professor G. Boriani (Modena, IT)

Access the full session

Session thumbnail
Atrial fibrillation and ablation or devices: what do registries tell us?

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 09:06 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources